12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Mangafodipir: Completed Phase IIa enrollment

PledPharma said investigators completed enrollment of 20 patients in the single-blind, placebo-controlled, Swedish Phase IIa MANAMI trial evaluating 2 µmol/kg IV mangafodipir in AMI patients undergoing...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >